Health
PharmAust secures Walter and Eliza Hall Institute as partner for HTLV-1 study – The West Australian
Perth-listed biotech PharmAust will investigate a treatment for a cancer-inducing virus through a new partnership with the Walter…

All subscriptions include exclusive subscriber offers, events and giveaways with West Rewards, our subscriber rewards program.
Continue Reading
-
General17 hours ago
Coroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
Business17 hours ago
Why Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
General19 hours ago
Too skewed, too gentlemanly | The Spectator Australia
-
General20 hours ago
Albanese beats drum on economy as trade clouds gather